ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,933, issued on Sept. 23, was assigned to NOVALIQ GMBH (Heidelberg, Germany).
"Ophthalmic composition for the treatment of uveitis" was invented by Jorg Haisser (Siegelsbach, Germany), Frank Loscher (Schriesheim, Germany), Chiara Silvana Leo (Heidelberg, Germany) and Markus Beier (Weinheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides pharmaceutical compositions comprising cyclosporine dissolved in a semifluorinated alkane for use in the treatment of uveitis."
The patent was filed on Sept. 5, 2020, under Application No. 17/640,679.
*For further information, including images, charts and tables, please visit: http://...